Life Science Compliance Update – Page 12 – Policy & Medicine

Examining the FY2015 Report on Medicaid Fraud Control Units

SEC Provides Explicit Whistleblower Guidance – Hunting Season Is Now Open

Value Based Contracts and Government Pricing

Helping the Patient – Co-Pay Reimbursement Can Be Okay in Certain Circumstances

The Blue Ribbon Panel Raises the Bar on Ethics & Compliance

Like Taxes and Inflation – HHS Revises Civil Monetary Penalties Upwards

BMS Settles with California Insurance Commission – Seems Everyone Is Getting Into the Act

How Realistic is the Yates Memo after Acclarent?

Opioids Under the Microscope – A Recap of Recent Events that Could Substantially Impact Compliance

EFPIA HCP Financial Disclosure Is Not Risk Free